Related Experiment Videos
Variations in flow, duration, and concentration do not change the final lung concentration of melphalan after
S Romijn1, J M H Hendriks, B P Van Putte
1Department of Thoracic and Vascular Surgery, University of Antwerp, Belgium.
Objective:
The influences of flow, perfusion time, and concentration on melphalan (MN) lung levels in a rat model of isolated lung perfusion (ILuP) were studied.
Methods:
ILuP was performed in WAG/Rij rats by using a single-pass system with 0.5, 0.05, 0.01, and 0.005 mg of MN. Subsequently ILuP with 0.05 mg MN was performed during 30 min with a flow rate of 0.5 ml/min, during 60 min with a flow rate of 0.5 ml/min, and during 30 min with a flow rate of 1.0 ml/min.
Results:
The lung MN levels of 0.05 mg were significantly lower as compared with 0.5 mg (p = 0.02). In the second experiment, no significant differences were seen in lung levels of MN between the different groups.
Conclusion:
The final lung MN levels were only determined by the absolute amount administered.
Insights
The total amount of melphalan (MN) administered, not flow rate or perfusion time, determined final lung MN levels in isolated lung perfusion (ILuP) rat models. Higher MN doses resulted in significantly higher lung MN levels.
Area of Science:
- Pharmacology
- Toxicology
- Surgical Techniques
Background:
- Isolated lung perfusion (ILuP) is a technique used to deliver drugs directly to the lungs.
- Understanding factors influencing drug distribution in the lungs is crucial for optimizing therapeutic outcomes and minimizing systemic toxicity.
- Melphalan (MN) is a chemotherapeutic agent used in the treatment of various cancers.
Purpose of the Study:
- To investigate the impact of varying melphalan (MN) concentrations, perfusion times, and flow rates on lung melphalan levels during isolated lung perfusion (ILuP) in a rat model.
- To determine the key factors that influence melphalan deposition and retention within the lung during ILuP.
Main Methods:
- Isolated lung perfusion (ILuP) was performed in WAG/Rij rats using a single-pass system.
- Experiments involved administering different doses of melphalan (MN): 0.5, 0.05, 0.01, and 0.005 mg.
- Further experiments varied perfusion time (30 or 60 min) and flow rate (0.5 or 1.0 ml/min) with a fixed 0.05 mg MN dose.
Main Results:
- Lung melphalan (MN) levels were significantly lower when 0.05 mg was administered compared to 0.5 mg (p = 0.02).
- No significant differences in lung MN levels were observed between groups when varying perfusion time and flow rate in the second experimental set.
Conclusions:
- The final melphalan (MN) lung levels achieved during isolated lung perfusion (ILuP) are primarily dictated by the absolute amount of the drug administered.
- Flow rate and perfusion duration did not significantly alter lung melphalan levels within the tested parameters in this rat model.